Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mersana Therapeutics Inc 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 USA

P: 617-498-0020

Description:

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 723,362
Enterprise Value, $K 570,042
Shares Outstanding, K 99,774
Annual Sales, $ 40 K
Annual Net Income, $ -170,060 K
Last Quarter Sales, $ 5,570 K
Last Quarter Net Income, $ -59,810 K
60-Month Beta 1.65
% of Insider Shareholders 4.40%
% of Institutional Shareholders 95.12%
Float, K 95,384
% Float 95.60%
Short Volume Ratio 0.22

Growth:

1-Year Return 9.19%
3-Year Return 70.99%
5-Year Return -54.14%
5-Year Revenue Growth -99.84%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.61 on 11/07/22
Next Earnings Date N/A
Earnings Per Share ttm -2.43
EPS Growth vs. Prev Qtr -10.91%
EPS Growth vs. Prev Year 3.17%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MRSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -171.23%
Return-on-Assets % -80.76%
Profit Margin % -425,150.00
Net Margin % N/A
Debt/Equity 0.18
Price/Sales 15,708.60
Price/Cash Flow N/A
Price/Book 7.29
Book Value/Share 0.93
Interest Coverage -132.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar